USD 0.38
(-3.8%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 910.07 Thousand USD | -43.46% |
2022 | 1.6 Million USD | 195.85% |
2021 | 544.03 Thousand USD | 7490.85% |
2020 | 7167.00 USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 1.1 Million USD | 21.11% |
2024 Q2 | 1.14 Million USD | 3.97% |
2024 Q3 | 1.09 Million USD | -4.5% |
2023 Q3 | 3.83 Million USD | 43.61% |
2023 Q1 | 2.37 Million USD | 3663.09% |
2023 Q2 | 2.67 Million USD | 12.32% |
2023 FY | 910.07 Thousand USD | -43.46% |
2023 Q4 | 910.07 Thousand USD | -76.28% |
2022 Q4 | 63.19 Thousand USD | 0.0% |
2022 FY | 1.6 Million USD | 195.85% |
2021 FY | 544.03 Thousand USD | 7490.85% |
2020 FY | 7167.00 USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 2.47 Billion USD | 99.963% |
Addus HomeCare Corporation | 317.73 Million USD | 99.714% |
AirSculpt Technologies, Inc. | 129.56 Million USD | 99.298% |
Amedisys, Inc. | 940.38 Million USD | 99.903% |
American Oncology Network, Inc. | 368.72 Million USD | 99.753% |
Astrana Health, Inc. | 522.59 Million USD | 99.826% |
Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 99.948% |
IMAC Holdings, Inc. | 1.89 Million USD | 52.02% |
biote Corp. | 191.84 Million USD | 99.526% |
Cryo-Cell International, Inc. | 72.25 Million USD | 98.74% |
Cross Country Healthcare, Inc. | 205.92 Million USD | 99.558% |
COMPASS Pathways plc | 50.24 Million USD | 98.189% |
DocGo Inc. | 185.28 Million USD | 99.509% |
The Ensign Group, Inc. | 2.68 Billion USD | 99.966% |
Healthcare Services Group, Inc. | 346.56 Million USD | 99.737% |
InnovAge Holding Corp. | 247.85 Million USD | 99.633% |
Assure Holdings Corp. | 22.84 Million USD | 96.017% |
The Joint Corp. | 62.37 Million USD | 98.541% |
LifeStance Health Group, Inc. | 804.27 Million USD | 99.887% |
Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | 76.121% |
ModivCare Inc. | 1.61 Billion USD | 99.944% |
NewGenIvf Group Limited | 1.24 Million USD | 26.692% |
Novo Integrated Sciences, Inc. | 11.06 Million USD | 91.774% |
Option Care Health, Inc. | 1.9 Billion USD | 99.952% |
P3 Health Partners Inc. | 427.3 Million USD | 99.787% |
P3 Health Partners Inc. | 427.3 Million USD | 99.787% |
The Pennant Group, Inc. | 394.17 Million USD | 99.769% |
Surgery Partners, Inc. | 3.65 Billion USD | 99.975% |
Talkspace, Inc. | 23.57 Million USD | 96.14% |
Talkspace, Inc. | 23.57 Million USD | 96.14% |
The Oncology Institute, Inc. | 162.39 Million USD | 99.44% |
The Oncology Institute, Inc. | 162.39 Million USD | 99.44% |